Materialise NV Working Capital

Working Capital of MTLS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Working Capital growth rates and interactive chart. Working capital, also known as net working capital (NWC), is the difference between a company’s current assets, such as cash, accounts receivable (customers’ unpaid bills) and inventories of raw materials and finished goods, and its current liabilities, such as accounts payable. Net operating working capital is a measure of a company's liquidity and refers to the difference between operating current assets and operating current liabilities. In many cases these calculations are the same and are derived from company cash plus accounts receivable plus inventories, less accounts payable and less accrued expenses. Working capital is a measure of a company's liquidity, operational efficiency and its short-term financial health. If a company has substantial positive working capital, then it should have the potential to invest and grow. If a company's current assets do not exceed its current liabilities, then it may have trouble growing or paying back creditors, or even go bankrupt.

Highlights and Quick Summary

  • Working Capital for the quarter ending June 29, 2021 was $175 Million (a 108.43% increase compared to previous quarter)
  • Year-over-year quarterly Working Capital increased by 77.93%
  • Annual Working Capital for 2020 was $89.9 Million (a -23.39% decrease from previous year)
  • Annual Working Capital for 2019 was $117 Million (a 8.99% increase from previous year)
  • Annual Working Capital for 2018 was $108 Million (a 174.21% increase from previous year)
Visit for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Working Capital of Materialise NV

Most recent Working Capitalof MTLS including historical data for past 10 years.

Interactive Chart of Working Capital of Materialise NV

Materialise NV Working Capital for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $174.88 $83.9
2020 $89.88 $98.29 $106.12 $110.54 $89.88
2019 $120.0 $122.61 $100.03 $103.66 $117.31
2018 $113.62 $117.65 $46.64 $45.07 $107.64
2017 $39.87 $51.38 $48.78 $50.61 $39.25
2016 $53.02 $46.32 $44.71 $46.63 $48.97
2015 $48.58 $45.76 $48.43 $55.55 $48.58
2014 $71.05 $89.54 $92.9 $71.05

Business Profile of Materialise NV

Sector: Technology
Industry: Software—Application
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. It operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.